Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient ...
Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional ...
MARIA, a 42-year-old teacher with an energetic spirit, had always been an active woman. However, one morning after a long ...
MedPage Today on MSN14d
What's With All the UFH Infusions for Acute Pulmonary Embolism?Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...
Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.
(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...
AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...
P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the ...
Hosted on MSN9d
William Blair Downgrades Inari Medical (NARI)Fintel reports that on January 7, 2025, William Blair downgraded their outlook for Inari Medical (NasdaqGS:NARI) from ...
Fintel on MSN8d
BTIG Downgrades Inari Medical (NARI)Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback